This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 August 2026.
All research outputs
#4,398,255
of 34,145,339 outputs
Outputs from Therapeutic Advances in Drug Safety
#91
of 378 outputs
Outputs of similar age
#51,145
of 404,530 outputs
Outputs of similar age from Therapeutic Advances in Drug Safety
#3
of 10 outputs
Altmetric has tracked 34,145,339 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 378 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.5. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 404,530 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.
